The chief pharmacy officer’s role in integrating artificial intelligence across the enterprise
American Journal of Health-System Pharmacy · 10.11.2026 · 83 (22) · 1301-1307
DOI: 10.1093/ajhp/zxag142 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Health-System Pharmacy, online erschienen am 05.05.2026. Verfasst von David Aguero und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Artificial intelligence (AI) will change healthcare, presenting both unprecedented opportunities and challenges as its capabilities double every 7 months, outpacing even Moore’s law in computer hardware.1 How the pharmacy profession will respond remains to be seen. This commentary will equip chief pharmacy officers (CPOs) with tools and ideas for integrating AI in support of the pharmacy enterprise. We aim to (1) define key terms and an approach to use-case vetting and governance; (2) describe workforce planning and engagement strategies; and (3) highlight practical actions to take and those that should be avoided. History reminds us that new technologies, such as the steam engine and the internet, took years to realize their promise (ie, the productivity paradox).2 While past innovations diffused gradually, the emergence of generative AI—particularly large language models (LLMs) and agentic AI—is poised to be swift and disruptive. Generative AI is expected to be revolutionary, but its impact is unfolding far more quickly than that of other general-purpose technologies because it builds on existing digital infrastructure and can be deployed instantly through natural language interfaces.3–6 These tools provide capabilities to the pharmacy enterprise today, including assisting with documentation, clinical decision support, medication reconciliation, and routine prior authorization.1,7 Table 1 outlines key AI terms and practice analogies used throughout this commentary, which can support leaders in early thinking about use cases and role implications. As excitement grows, pharmacy leaders face the challenge of distinguishing hype from true innovation to deliver lasting and measurable value in medication use.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.
- Department of Pharmaceutical Services, University of California, San Francisco (UCSF) Health, San Francisco, CA, USA.
- Vizient, Inc., Chicago, IL, USA.
- Pharmacy Enterprise, Cleveland Clinic, Cleveland, OH, USA.
- Community Care Services, Henry Ford Health, Bingham Farms, MI, USA.
Zitieren
APA
Aguero, D., Gross, K., Shaw, B. G., Amerine, L. B., & Tryon, J. (2026). The chief pharmacy officer’s role in integrating artificial intelligence across the enterprise. American Journal of Health-System Pharmacy, 83(22), 1301-1307. https://doi.org/10.1093/ajhp/zxag142
Vancouver
Aguero D, Gross K, Shaw BG, Amerine LB, Tryon J. The chief pharmacy officer’s role in integrating artificial intelligence across the enterprise. American Journal of Health-System Pharmacy. 2026;83(22):1301-1307. doi:10.1093/ajhp/zxag142
BibTeX
@article{Aguero2026,
author = {Aguero, David and Gross, Kendall and Shaw, Bryan G and Amerine, Lindsey B and Tryon, Jennifer},
title = {The chief pharmacy officer’s role in integrating artificial intelligence across the enterprise},
journal = {American Journal of Health-System Pharmacy},
year = {2026},
volume = {83},
number = {22},
pages = {1301--1307},
doi = {10.1093/ajhp/zxag142}
}
EUVIMED